Evidence map›Paper›PMID 19744691›Full record

ArticleVirology2009

Complement modulates pathogenesis and antibody-dependent neutralization of West Nile virus infection through a C5-independent mechanism.

Erin Mehlhop, Anja Fuchs, Michael Engle, Michael S Diamond

Open access · greenAbstract read
In one paragraph

Article in Virology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 35 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. In the Crosshairs: RNA Viruses OR Complement?Frontiers in immunology · 2020
    Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. The Complement System in Flavivirus Infections.Frontiers in microbiology · 2017
    Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. West Nile virus infection and immunity.Nature reviews. Microbiology · 2013
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Erin MehlhopDepartment of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Anja Fuchs
Michael Engle
Michael S Diamond
Washington University in St. Louis · US

Funding

Virology and Smallpox VaccinationsU54AI057160 · NIAID · WASHINGTON UNIVERSITY · PI YOKOYAMA, WAYNE M. · 2003 to 2013
$80.9M
Monoclonal Antibody Therapy for West Nile VirusU01AI061373 · NIAID · WASHINGTON UNIVERSITY · PI DIAMOND, MICHAEL S · 2005 to 2009
$5.1M
NIAID NIH HHS U01 AI061373NIAID NIH HHS U54 AI057160NIAID NIH HHS U54AI057160
6 · The paper itself

Abstract

Although the interactions of complement and viruses have been widely studied, the function of C5 and the membrane attack complex in the context of viral infection or antibody-mediated neutralization remains controversial. Using C5-depleted or -deficient human or mouse sera, we show that C5 does not contribute to the antibody-dependent or -independent neutralization of West Nile virus (WNV) in cell culture. Consistent with this, C5 neither contributed to protection against WNV pathogenesis nor augmented the neutralizing efficacy of complement-fixing anti-WNV neutralizing antibodies in mice. Although previous studies established that activation of the classical, lectin, and alternative complement pathways restricts WNV infection, our results show little effect of C5 and by inference the terminal lytic complement components. Overall, these results enhance our mechanistic understanding of how complement controls flavivirus infections.

Indexed as

AnimalsAntibodies, ViralComplement C5HumansMaleMiceNeutralization TestsSurvival AnalysisViral Plaque AssayWest Nile FeverWest Nile virusAntibodies, ViralComplement C5

Identifiers

PMID19744691
PMCPMC2753729
OpenAlexW2038558750

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.